These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33311501)

  • 41. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.
    Geoghegan JL; Douglas J; Ren X; Storey M; Hadfield J; Silander OK; Freed NE; Jelley L; Jefferies S; Sherwood J; Paine S; Huang S; Sporle A; Baker MG; Murdoch DR; Drummond AJ; Welch D; Simpson CR; French N; Holmes EC; de Ligt J
    Emerg Infect Dis; 2021 May; 27(5):1317-1322. PubMed ID: 33900175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Turnover of SARS-CoV-2 Lineages Shaped the Pandemic and Enabled the Emergence of New Variants in the State of Rio de Janeiro, Brazil.
    Francisco Junior RDS; Lamarca AP; de Almeida LGP; Cavalcante L; Machado DT; Martins Y; Brustolini O; Gerber AL; Guimarães APC; Gonçalves RB; Alves C; Mariani D; Cruz TF; de Souza IV; de Carvalho EM; Ribeiro MS; Carvalho S; da Silva FD; Garcia MHO; de Souza LM; da Silva CG; Ribeiro CLP; Cavalcanti AC; de Mello CMB; Struchiner CJ; Tanuri A; de Vasconcelos ATR
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation in volumes and characteristics of trauma patients admitted to a level one trauma centre during national level 4 lockdown for COVID-19 in New Zealand.
    Christey G; Amey J; Campbell A; Smith A
    N Z Med J; 2020 Apr; 133(1513):81-88. PubMed ID: 32325471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Transmission Dynamics, Spread, and Genomic Characterization of SARS-CoV-2 in Panama.
    Franco D; Gonzalez C; Abrego LE; Carrera JP; Diaz Y; Caicedo Y; Moreno A; Chavarria O; Gondola J; Castillo M; Valdespino E; Gaitán M; Martínez-Mandiche J; Hayer L; Gonzalez P; Lange C; Molto Y; Mojica D; Ramos R; Mastelari M; Cerezo L; Moreno L; Donnelly CA; Pascale JM; Faria NR; Lopez-Verges S; Martinez AA;
    Emerg Infect Dis; 2021 Feb; 27(2):612-615. PubMed ID: 33496228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New Zealand.
    Steyn N; Binny RN; Hannah K; Hendy SC; James A; Kukutai T; Lustig A; McLeod M; Plank MJ; Ridings K; Sporle A
    N Z Med J; 2020 Sep; 133(1521):28-39. PubMed ID: 32994635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China.
    Yuan Y; He J; Gong L; Li W; Jiang L; Liu J; Chen Q; Yu J; Hou S; Shi Y; Lu S; Zhang Z; Ge Y; Sa N; He L; Wu J; Sun Y; Liu Z
    BMC Infect Dis; 2020 Dec; 20(1):930. PubMed ID: 33287717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From People to
    McAloose D; Laverack M; Wang L; Killian ML; Caserta LC; Yuan F; Mitchell PK; Queen K; Mauldin MR; Cronk BD; Bartlett SL; Sykes JM; Zec S; Stokol T; Ingerman K; Delaney MA; Fredrickson R; Ivančić M; Jenkins-Moore M; Mozingo K; Franzen K; Bergeson NH; Goodman L; Wang H; Fang Y; Olmstead C; McCann C; Thomas P; Goodrich E; Elvinger F; Smith DC; Tong S; Slavinski S; Calle PP; Terio K; Torchetti MK; Diel DG
    mBio; 2020 Oct; 11(5):. PubMed ID: 33051368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-resolution epidemiological landscape from  ~290,000 SARS-CoV-2 genomes from Denmark.
    Khurana MP; Curran-Sebastian J; Scheidwasser N; Morgenstern C; Rasmussen M; Fonager J; Stegger M; Tang ME; Juul JL; Escobar-Herrera LA; Møller FT; ; Albertsen M; Kraemer MUG; du Plessis L; Jokelainen P; Lehmann S; Krause TG; Ullum H; Duchêne DA; Mortensen LH; Bhatt S
    Nat Commun; 2024 Aug; 15(1):7123. PubMed ID: 39164246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing SARS-CoV-2 sequence diversity of Pakistani isolates.
    Rehman Z; Umair M; Ikram A; Amir A; Salman M
    Infect Genet Evol; 2021 Jun; 90():104752. PubMed ID: 33545393
    [No Abstract]   [Full Text] [Related]  

  • 51. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.
    Li J; Wang H; Mao L; Yu H; Yu X; Sun Z; Qian X; Cheng S; Chen S; Chen J; Pan J; Shi J; Wang X
    Sci Rep; 2020 Oct; 10(1):17492. PubMed ID: 33060796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic Epidemiology of SARS-CoV-2 in Pakistan.
    Song S; Li C; Kang L; Tian D; Badar N; Ma W; Zhao S; Jiang X; Wang C; Sun Y; Li W; Lei M; Li S; Qi Q; Ikram A; Salman M; Umair M; Shireen H; Batool F; Zhang B; Chen H; Yang YG; Abbasi AA; Li M; Xue Y; Bao Y
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):727-740. PubMed ID: 34695600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Geoghegan JL; Moreland NJ; Le Gros G; Ussher JE
    Nat Immunol; 2021 Mar; 22(3):262-263. PubMed ID: 33627881
    [No Abstract]   [Full Text] [Related]  

  • 54. The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.
    Baker MG; Kvalsvig A; Crengle S; Harwood M; Tukuitonga C; Betty B; Bonning J; Wilson N
    N Z Med J; 2021 Nov; 134(1546):8-16. PubMed ID: 34855729
    [No Abstract]   [Full Text] [Related]  

  • 55. Emerging SARS-CoV-2 Diversity Revealed by Rapid Whole-Genome Sequence Typing.
    Moustafa AM; Planet PJ
    Genome Biol Evol; 2021 Sep; 13(9):. PubMed ID: 34432021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impacts of Low Diversity Sequence Data on Phylodynamic Inference during an Emerging Epidemic.
    Lam A; Duchene S
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33430050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity.
    Bolyen E; Dillon MR; Bokulich NA; Ladner JT; Larsen BB; Hepp CM; Lemmer D; Sahl JW; Sanchez A; Holdgraf C; Sewell C; Choudhury AG; Stachurski J; McKay M; Simard A; Engelthaler DM; Worobey M; Keim P; Caporaso JG
    F1000Res; 2020; 9():657. PubMed ID: 33500774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 Australia: Epidemiology Report 33 Fortnightly reporting period ending 17 January 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Jan; 45():. PubMed ID: 33499797
    [No Abstract]   [Full Text] [Related]  

  • 59. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.
    Pang J; Boshier FAT; Alders N; Dixon G; Breuer J
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32907921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.